TGFB1 and pulmonary fibrosis: The cytokine TGF-β has been proposed to play a key role in lung fibrosis (Tatler and Jenkins, 2012), and drugs able to control TGF-β expression and/or signaling seem to be active in reducing fibroblast activation and clinical progression of the disease (Bonniaud et al., 2005).